Wynn Resorts (WYNN)
83.36
-2.31 (-2.70%)
Wynn Resorts is a leading global developer and operator of luxury hotels and casinos, renowned for its high-end hospitality offerings and extravagant entertainment experiences
The company manages iconic resorts that feature world-class amenities, fine dining restaurants, vibrant nightlife, and extensive gaming facilities. With a focus on delivering exceptional customer service and innovative entertainment options, Wynn Resorts creates unique environments that cater to both leisure and business travelers, while also contributing to the tourism and hospitality industry in the destinations where it operates.
Previous Close | 85.67 |
---|---|
Open | 84.94 |
Bid | 83.33 |
Ask | 83.38 |
Day's Range | 83.34 - 85.92 |
52 Week Range | 71.63 - 110.38 |
Volume | 1,091,416 |
Market Cap | 9.64B |
PE Ratio (TTM) | 19.61 |
EPS (TTM) | 4.3 |
Dividend & Yield | 1.000 (1.20%) |
1 Month Average Volume | 2,961,103 |
News & Press Releases

Most consumer discretionary businesses succeed or fail based on the broader economy. This sensitive demand profile can cause the industry to stumble when macro uncertainty enters the fray,
and over the past six months, its returns were flat.
This performance was similar to the S&P 500.
Via StockStory · March 12, 2025

Leann Griffin, Vixen Aesthetics' CEO, leads advanced courses at 2025's Vegas Cosmetic Surgery and The Aesthetic Show
Via PRUnderground · March 10, 2025

The US market session of Friday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.
Via Chartmill · March 7, 2025

Via The Motley Fool · March 4, 2025

This CME Symposium takes place on Wednesday, April 30, 2025, from 8:00-9:30 PM PT during Asembia's AXS25 Summit at the Wynn Las Vegas in Las Vegas, Nevada.HAZLET, N.J. - March 10, 2025 - PRLog -- In this educational initiative, to take place at the 2025 AXS Specialty Pharmacy meeting, a multidisciplinary faculty—consisting of two hyperkalemia experts in heart failure (one cardiologist, Dr. Stephen Greene and one pharmacist, Dr. Robert Page) and two hyperkalemia experts in chronic kidney disease (one nephrologist, Dr. Csaba Kovesdy and one pharmacist, Dr. Joanna Hudson) will explain the cardiovascular risks associated with discontinuing/reducing the dose of RAASi therapy due to hyperkalemia and the clinical evidence with novel potassium binders for reducing serum potassium and facilitating maintenance of RAASi therapy. Roles of specialty pharmacists in the management of patients with hyperkalemia will be identified, and clinical practice pearls will be described. A case presentation and faculty discussion of a patient with HF, CKD and hyperkalemia at high cardiorenal risk will provide attendees with best practices and key take-home messages.This program is jointly provided by Postgraduate Institute for Medicine and Voxmedia LLC.Click here for more information and to registerCO-CHAIRSJoanna Hudson, PharmD, BCPSProfessorDepartments of Clinical Pharmacy and Translational Science & Medicine (Nephrology)The University of Tennessee Health Science CenterMemphis, TennesseeRobert Page, PharmD, MSPH, BCPS, BCGPProfessorDepartments of Clinical Pharmacy and Physical MedicineSkaggs School of Pharmacy and Pharmaceutical SciencesCU AnschutzAurora, ColoradoFACULTYStephen Greene, MDAssociate Professor of MedicineDuke University School of MedicineDuke Clinical Research InstituteDurham, North CarolinaCsaba Kovesdy, MDFred Hatch Professor of MedicineUniversity of Tennessee Health Science CenterMemphis VA Medical CenterMemphis, TennesseeEducational Objectives:
Via PRLog · March 10, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Via StockStory · March 4, 2025

Gaming, betting and entertainment company Bally's Corporation (NYSEBALY)
will be announcing earnings results tomorrow after market close. Here’s what to look for.
Via StockStory · March 4, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Monday?
Via Chartmill · March 3, 2025

Via The Motley Fool · February 27, 2025

Casino, sports betting and entertainment operator PENN Entertainment (NASDAQPENN)
will be reporting results tomorrow before the bell. Here’s what to look for.
Via StockStory · February 26, 2025

Casino, tavern, and slot machine operator Golden Entertainment (NASDAQGDEN)
will be announcing earnings results tomorrow after market hours. Here’s what to look for.
Via StockStory · February 26, 2025

Hotel and casino entertainment company Caesars Entertainment (NASDAQCZR)
will be reporting results tomorrow after the bell. Here’s what investors should know.
Via StockStory · February 24, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at consumer discretionary stocks, starting with Bowlero (NYSEBOWL).
Via StockStory · February 18, 2025

Via Benzinga · February 18, 2025

Via Benzinga · February 18, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how consumer discretionary stocks fared in Q4, starting with Bowlero (NYSEBOWL).
Via StockStory · February 17, 2025

Shares of luxury hotels and casino operator Wynn Resorts (NASDAQWYNN)
jumped 10.7% in the afternoon session after the company reported strong fourth-quarter results that blew past analysts' EPS and revenue estimates. However, Casino revenue came in below expectations, with weakness in Wynn Macau offsetting gains in Wynn Palace and Las Vegas. Adjusted property EBITDAR declined slightly as softer results in Macau and Encore Boston Harbor weighed on overall profitability.
Via StockStory · February 14, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Via Chartmill · February 14, 2025

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill · February 14, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · February 14, 2025

WYNN earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 13, 2025

Wynn Resorts also declared a cash dividend of $0.25 per share, payable on March 5, 2025.
Via Stocktwits · February 14, 2025

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.
Via Benzinga · February 14, 2025

Luxury hotels and casino operator Wynn Resorts (NASDAQWYNN) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.84 billion. Its non-GAAP profit of $2.42 per share was 91.1% above analysts’ consensus estimates.
Via StockStory · February 13, 2025